Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
City of Hope Medical Center
Case Comprehensive Cancer Center
Valo Therapeutics Oy
Acepodia Biotech, Inc.
BioEclipse Therapeutics
Fate Therapeutics
Fate Therapeutics
BGI, China
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Cancer Research UK